•  
  •  
  •  
  •  

2026-08-12 06:50:48

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT

Keywords Selected:  Permission

Stock Report

  • AstraZeneca Pharma India Ltd receives permission from CDSCO for Datopotamab Deruxtecan powder
  • AstraZeneca Pharma India Ltd receives permission from CDSCO for Durvalumab Solution
  • AstraZeneca Pharma India Ltd receives permission for Olaparib film-coated tablets
  • Alfavision Overseas India Ltd updates on permission for harvesting of teakwood trees
  • AstraZeneca Pharma India Ltd receives permission to import new drug
  • Zydus receives approval from USFDA to initiate Phase II clinical trial of ZYIL1 in patients with Parkinson's disease
  • AstraZeneca Pharma India Ltd receives permission from CDSCO to import new drug
  • AstraZeneca Pharma India Ltd receives permission to Import pharmaceutical formulations of new drug for sale
  • AstraZeneca Pharma India receives permission to import Palivizumab solution for injection
  • Poonawalla Fincorp partners with IndusInd Bank for co-branded credit card, gets RBI permission
  • Som Distilleries and Breweries Ltd gets nod for supplying its beer brands in Chhattisgarh
  • NDTV gets nod for 4 new channels
  • Som Distilleries and Breweries Ltd's beer brands receives permission for supply to Rajasthan
  • AstraZeneca Pharma India Ltd receives permission for sale and distribution of Trastuzumab deruxtecan
  • KCL Infra Projects Ltd receives permission to uplink and downlink non News TV Channel
  • Tergene Biotech Pvt. Ltd receives SEC recommendation for pneumococcal 15 valent vaccine
  • AstraZeneca Pharma India receives permission for Dapagliflozin tablets
  • Balaji Amines completes Phase 1 of Greenfield Project
  • Federal Bank enables Utility Bill Payment Services in its Cross Border Remittance Platform
  • HIKAL restarts manufacturing at Taloja plant
  • Praveg Communications India Ltd receives permission for News and Current Affairs Satellite TV Channel
  • Kimia Biosciences Ltd gets permission for Bemopedoic acid bulk drug
  • CoSara Diagnostics gets permission from CDSCO for SARAQ™ Hepatitis C Viral Load Kit as an IVD

Latest Post

  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025